Unknown

Dataset Information

Assessing site performance in the Altair study, a multinational clinical trial.


ABSTRACT:

Background

Reviewing clinical trial site performance identifies strategies to control outcomes. Performance across 5 geographical regions (36 sites across Asia, Australia, Europe, North America and Latin America) was investigated in a study that randomised 322 HIV-infected individuals.

Methods

Regional performance was compared using descriptive analysis for time to site opening, recruitment, quality of data and laboratory samples. Follow-up consisted of 10 visits (96 weeks), electronic data collection (EDC) within 7 days of a visit and serious adverse events (SAEs) reported within 24 hours of site awareness.

Results

Median days to site opening was 250 (188 to 266), ranging from 177 (158 to 200) (Australia) to 265 (205 to 270) (Europe). Median days to ethics and regula

SUBMITTER: Berthon-Jones N 

PROVIDER: S-EPMC4412197 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature